{
  "id": 198563,
  "name": "ALNYLAM PHARMACEUTICALS, INC.",
  "slug": "alnylam-pharmaceuticals-inc",
  "state": "MA",
  "description": "Biopharmaceutical company",
  "totalSpending": 1390000,
  "filings": 30,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 60000
    },
    {
      "year": 2019,
      "income": 90000
    },
    {
      "year": 2020,
      "income": 90000
    },
    {
      "year": 2021,
      "income": 210000
    },
    {
      "year": 2022,
      "income": 200000
    },
    {
      "year": 2023,
      "income": 200000
    },
    {
      "year": 2024,
      "income": 300000
    },
    {
      "year": 2025,
      "income": 240000
    }
  ],
  "firms": [
    "TODD STRATEGY GROUP"
  ],
  "lobbyists": [
    "DANIEL TODD",
    "PAUL EDATTEL",
    "NICHOLAS UEHLECKE",
    "JEFF LUCAS",
    "KATHERINE COTTON",
    "ERIC BERGREN",
    "TED LEHMAN",
    "TAYLOR SEXTON",
    "KIMBERLY LINTHICUM",
    "NICK MAGALLANES"
  ],
  "issues": [
    "MMM",
    "HCR",
    null
  ],
  "sampleDescriptions": [
    "Medicare coverage and reimbursement.",
    "COVID-19 Response.",
    "Medicare coverage and reimbursement.\nHome infusion.",
    "Medicare coverage and reimbursement.\nHome infusion.\nPart B Rebates.",
    "Medicare coverage and reimbursement.\nHome infusion.\nH.R.5376 - Build Back Better Act.\nH.R.3684 - Infrastructure Investment and Jobs Act.",
    "Medicare coverage and reimbursement. Home Infusion. H.R.5376 - Build Back Better Act.",
    "Medicare coverage and reimbursement. Home Infusion. H.R.5376 - Build Back Better Act. FDA regulation of platform technologies.",
    "Medicare coverage and reimbursement. Home Infusion. H.R.5376 - Inflation Reduction Act of 2022. FDA regulation of platform technologies.",
    "Medicare and Medicaid Issues. MINI Act. ORPHAN Act. Food and Drug Omnibus Reform Act of 2022.",
    "Medicare and Medicaid Issues H.R.5547/S.476 - Maintaining Investments in New Innovation (MINI) Act. H.R.5539/S.3131 - ORPHAN Cures Act. Home Infusion.",
    "Medicare and Medicaid Issues. H.R.5547/S.476 - Maintaining Investments in New Innovation (MINI) Act. H.R.5539/S.3131 - ORPHAN Cures Act. Home infusion.",
    "Medicare and Medicaid Issues H.R.1672 - Maintaining Investments in New Innovation Act. H.R.946 - ORPHAN Cures Act. Home infusion.",
    "Medicare and Medicaid Issues H.R.1672 - Maintaining Investments in New Innovation Act. H.R.946 - ORPHAN Cures Act."
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 300,
  "trajectory": "exploding",
  "yearsActive": 8,
  "avgAnnualSpending": 173750,
  "peakYear": 2024,
  "lobbyistCount": 10,
  "firmCount": 1,
  "issueCount": 2,
  "industry": "healthcare"
}